Akdital stock reports 19 percent revenue growth in H1 2026

Published on 09/28/2026 at 10:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Akdital stock reflects MAD 2.482 billion in H1 2026 revenue through June 30, versus MAD 2.093 billion a year earlier. Saudi expansion adds a 126-bed project.

AKT, MA0000012585, Illustration mit AI erstellt.

Akdital (ISIN MA0000012585) stock was quoted at MAD 1,146.00 on the Casablanca Stock Exchange on September 25, 2026, with a daily change of -0.17 percent. The company completed its majority acquisition of Al Bishri Hospital in Mecca on September 21, adding a Saudi expansion step to its Moroccan health care platform.

Revenue reaches MAD 2.482 billion

Akdital generated consolidated revenue of MAD 2.482 billion in the first half of 2026, compared with MAD 2.093 billion in the first half of 2025, an increase of 19 percent, according to Le Desk on August 31, 2026. Second-quarter revenue reached MAD 1.282 billion, up 11 percent from the same quarter a year earlier.

The operating base also expanded. The group had 45 facilities in 25 Moroccan cities and 4,864 beds at June 30, 2026, while admissions rose to 590,842 from 514,118 a year earlier, according to Le Desk.

Saudi hospital adds capacity

The Al Bishri transaction gives Akdital a second Saudi growth platform. The renamed Akdital Makkah Al Mukarramah hospital is planned to reach 126 beds, compared with 120 before the renovation and extension program, LeBrief reported on September 21, 2026. The planned facility includes emergency, intensive-care, cardiology, surgery and maternal and child health services.

Expansion is accompanied by higher financial leverage. Net consolidated debt stood at MAD 4.916 billion at June 30, 2026, compared with MAD 4.268 billion at December 31, 2025, an increase of 15 percent, according to Le Desk. Net investment fell to MAD 403 million in the first half from MAD 966 million a year earlier, a decline of 58 percent.

AKT valuation stays in view

BMCE Capital Bourse showed a Buy recommendation dated June 3, 2026, and a price target of MAD 1,868.00 for Akdital, with the stock quote on that page dated September 10, 2026, according to BMCE Capital Bourse. The target is materially above the September 25 quotation, leaving the market to weigh expansion potential against debt and investment requirements.

Stock trades at MAD 1,146.00

AKT was quoted at MAD 1,146.00 on the Casablanca Stock Exchange on September 25, 2026. The stock had a 52-week range of MAD 975.00 to MAD 1,540.00 and market capitalization of MAD 16.1 billion as of September 17, 2026.